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Abstract
Despite extensive investigations, restenosis, which is characterized primarily by neointima formation, remains an unsolved
clinical problem after vascular interventions. A recent study has shown that CD40 signaling through TNF receptor associated
factor 6 (TRAF6) plays a key role in neointima formation after carotid artery injury; however, underlying mechanisms are not
clearly elucidated. Because neointima formation may vary significantly depending on the type of injury, we first assessed the
effect of CD40 deficiency on neointima formation in 2 injury models, carotid artery ligation and femoral artery denudation
injury. Compared with wild-type mice, CD40 deficiency significantly reduced neointima formation and lumen stenosis in
two different models. Further, we investigated the mechanism by which CD40 signaling affects neointima formation after
arterial injury. In wild-type mice, the expression levels of CD40, several TRAF proteins, including TRAF1, TRAF2, TRAF3,
TRAF5, and TRAF6, as well as total NF-kB p65 and phospho-NF-kB p65, in the carotid artery were markedly upregulated
within 3–7 days after carotid ligation. Deficiency of CD40 abolished the injury-induced upregulation of TRAFs including
TRAF6 and NF-kB-p65 in the injured vessel wall. Further, CD40
2/2 mice showed a significant decrease in the recruitment of
neutrophils (at 3, 7d) and macrophages (at 7, 21d) into injured artery; this effect was most likely attributed to inhibition of
NF-kB activation and marked downregulation of NF-kB-related gene expression, including cytokines (TNFa, IL-1b, IL-6),
chemokines (MCP-1), and adhesion molecules (ICAM-1, VCAM-1). Moreover, neutrophil recruitment in a model of
thioglycollate-induced peritonitis is impaired in CD40-deficient mice. In vitro data revealed that CD40 deficiency blocked
CD40L-induced NF-kB p65 nuclear translocation in leukocytes. Altogether, our data identified for the first time that CD40 is
essential in the upregulation of TRAF6, NF-kB activation, and NF-kB-dependent proinflammatory genes in vivo. Our findings
firmly established the role for CD40 in neointima formation in 2 distinct injury models.
Citation: Song Z, Jin R, Yu S, Rivet JJ, Smyth SS, et al. (2011) CD40 Is Essential in the Upregulation of TRAF Proteins and NF-KappaB-Dependent Proinflammatory
Gene Expression after Arterial Injury. PLoS ONE 6(8): e23239. doi:10.1371/journal.pone.0023239
Editor: Alma Zernecke, Universita ¨tW u ¨rzburg, Germany
Received April 13, 2011; Accepted July 9, 2011; Published August 18, 2011
Copyright:  2011 Song et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health grant HL087990 (GL) and by a scientist development grant (0530166N, GL) from the American
Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: gli@lsuhsc.edu
. These authors contributed equally to this work.
Introduction
The CD40/CD40L system has been implicated in several
cardiovascular diseases, such as atherosclerosis, ischemic heart
disease, and stroke [1,2]. Accumulating evidence indicates that
CD40 signaling is mediated principally through tumor necrosis
factor receptor–associated factors (TRAFs) [3,4]. TRAFs are
cytoplasmic adaptor proteins for the TNF/interleukin-1/Toll-like
receptor superfamily. Ligands of this family comprise multiple pro-
inflammatory cytokines such as CD40L, TNF-a, and interleukin-
1b. TRAFs serve as adapter molecules linking CD40 to
downstream signaling pathways. Different TRAFs exhibit specific
biological functions [5–7]. The roles of individual TRAFs in the
activation of different CD40-dependent signaling pathways have
not been fully defined [7]. Establishing the significance and
interplay of these roles will lead to a more complete understanding
of mechanisms important to the CD40-mediated activation of the
immune system and will reveal novel targets for the development
of therapeutic agents [7].
The cytoplasmic domain of CD40 contains 2 independent
membrane TRAF-binding domains: a proximal region binding
TRAF6, and a distinct distal domain that binds TRAF-1/2/3/5
[4]. CD40-TRAFs signal transduction cascades are multiple and
complex. Different TRAFs binding to CD40 triggers distinct
signaling pathways leading to a variety of functional outcomes,
depending on the cell type(s) involved [8]. For example, in
monocytes and macrophages, TRAF6 is an essential mediator of
CD40-activated proinflammatory pathways via activation of NF-
kB and Src/ERK1/2 pathways [9], while in endothelial cells
(ECs), inflammation is predominantly mediated via CD40-TRAF2
interactions [10]. However, there are currently no data available
regarding whether such a CD40-mediated proinflammatory
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to vascular injury.
Although a pivotal role of CD40L in atherogenesis has been
proven extensively [1,3,11,12], only a few reports have investigat-
ed CD40-TRAF-dependent functions in the context of vascular
injury. Miyahara et al [13] reported that among the TRAFs
members, TRAF6 is predominantly involved in the process of
inflammatory response and in-stent lesion formation in a stent
implantation model of rabbit carotid artery. More recently,
Donners et al [14] reported that the CD40-TRAF6 in bone
marrow-derived cells plays a dominant role in neointima
formation and arterial remodeling in a mouse carotid artery
ligation model. However, there is clear evidence that the
contribution of bone marrow-derived cells to neointima formation
is rather limited in the mouse carotid artery ligation model.
In the present study, we investigated the role of CD40 in
regulation of its adaptor proteins TRAFs and NF-kB-dependent
proinflammatory genes in response to vascular injury. It is well
known that neointima formation may vary significantly depending
on the type of injury [14,15]. Moreover, deficiency of the same
genes (e.g. CD40L, integrin beta3) may have different and even
opposite effects on neointima formation in different injury models
[15,16]. Thus, it is imperative to determine whether or not the
CD40-mediated effect on neoinitma formation is model-specific.
Therefore, we examined and compared the effect of CD40
deficiency on neointima formation and arterial remodeling using
two distinct injury models, the guidewire-induced femoral artery
denudation and the carotid artery ligation.
Methods
Ethics statement
All experimental procedures were carried out in accordance
with the NIH Guide for the Care and Use of Laboratory Animals
and approved by the Animal Care and Use Committee of the
Louisiana State University Health Science Center-Shreveport
(IACUC approval number: 0819). Male C57BL/6 mice and
CD40
2/2 mice (backcrossed onto a C57BL/6 background for
.10 generations) were obtained from The Jackson Laboratory
(Bar Harbor, ME).
Two vascular injury models
In this study, two distinct types of mechanical vascular injuries
were performed in the same mouse as previously reported [17].
Both left common carotid artery and left femoral artery of each
mouse were injured to induce neointima formation. Mice were
anesthetized with intraperitoneal administration of ketamine
(80 mg/kg body wt; Abbott Laboratories) and xylazine (5 mg/kg
body wt; Rompun, Bayer Corp). Carotid artery ligation was
performed as described previously [18]. In brief, the left common
carotid artery was exposed through a small midline incision in the
neck and the artery was completely ligated with a 7-0 silk suture
just proximal to the carotid bifurcation to disrupt blood flow.
Endothelial denudation of mouse femoral arteries was performed
as previously described [19] In brief, the left femoral artery and its
muscular branch were exposed, and a 0.0149 (0.36 mm) diameter
angioplasty guide wire was introduced into the arterial lumen and
advanced to the level of the aortic bifurcation and pulled back
three times. Removal of the endothelium was confirmed by in vivo
Evan’s blue staining in injured arteries compared with noninjured
arteries (Figure S1). Animals were sacrificed at defined time points
after injury. After in situ cardiac perfusion with 4% paraformal-
dehyde or saline, arteries were collected for histology or
biochemical analysis as previously described [19,20].
Histology and morphometry
The arterial segments were dehydrated in ethanol and xylene
and embedded in paraffin. Serial cross-sections (5 mm thick) were
cut beginning 100 mm proximal to the carotid ligation site or the
femoral bifurcation. Histomorphometric analysis was performed at
7 cross-section levels (with 120 mm intervals) (Figure S3A). For
each level, three cross-sections were stained with Verhoeff’s Elastic
staining and morphometric analysis was performed by an
individual blinded to experimental design. We measured the
lumen area, intimal area (the area within the internal elastic
lamina [IEL] minus the lumen area), medial area (defined as the
area within the external elastic lamina [EEL] minus the area
within the IEL), and total vessel area (the area encompassed by the
EEL) at each level as previously described [14,20]. The mean
value of neointimal area, intima/media ratio, lumen stenosis ratio,
and total vessel area was calculated over 7 cross-section levels.
Immunohistochemistry
Paraffin-embedded sections were stained with the avidin-biotin-
peroxidase method (Vector Laboratories). The following primary
antibodies (from Santa Cruz, unless otherwise indicated) were used:
CD40 (1:1000), TRAF1 (1:25), TRAF2 (1:50), TRAF3 (1:1000),
TRAF5 (1:400), TRAF6 (1:50), ICAM-1 (1:50), VCAM-1 (1:50),
MCP-1 (1:1000), NF-kB p65 (1:750; Abcam), Phospho-p65
(phosphor Ser536; 1:50; Abcam),Mac-2 (1:1000; M3/38, Accurate)
to detect monocyte/macrophages, and anti-PMN mAb (1:2500;
Accurate) to detect neutrophils. Isotype-matched antibodies served
as negative controls. Sections were incubated with the appropriate
secondary antibody (Vector Laboratories) and visualized by 3,39-
diaminobenidine (DAB; Vector Laboratories) and counterstained
with hematoxylin. For quantitative comparison of leukocyte
infiltration, the percent of the positively stained cells to the total
cells was calculated. For quantitative comparison of the expression
of indicated molecules, the percent of the positively stained area to
the total traced area was determined. Morphometric and
immunohistochemical analysis were performed by one blinded
investigator using Image Pro Plus 5.0 (Media Cybernetics).
Real-time RT-PCR
Total RNA was extracted from pooled carotid arteries (n=5)
using TRIzol Reagent (Invitrogen) and treated with DNase I to
remove genomic DNA. A quantitative real-time reverse-transcrip-
tase (RT)-PCR was performed with a Bio-Rad thermocycler and
an SYBR green kit (Bio-Rad) according to the recommendations
of the manufacturer. Sequence-specific primers used for the
reaction are presented in Table S2. The relative mRNA expression
was normalized by GAPDH RNA levels. Data are expressed as the
fold change compared to uninjured arteries.
Thioglycollate-elicited peritonitis model
Peritoneal recruitment of leukocytes was induced using 2.0 ml
of sterile 3% thioglycollate (Sigma-Aldrich) as we described
previously [20]. After 5 hours, mice were killed, the peritoneal
cavity was rinsed with 5 mL ice-cold PBS containing 0.1% BSA
and 20 mmol/L disodium EDTA. Cell viability (trypan blue
exclusion) was .95% and Cytospin preparations stained with
Giemsa revealed that .90% of the cells were neutrophils. The
number of neutrophils in the peritoneal fluid was counted with a
hemocytometer (Hausser Scientific).
NF-kB p65 nuclear translocation assay
Isolated neutrophils were resuspended in RPMI 1640 contain-
ing 0.5% (w/v) low-endotoxin BSA. The effect of CD40 on the
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tochemical method as previously described [21,22]. In brief,
freshly isolated neutrophils were stimulated with 1.0 mg/ml
CD40L (R&D Systems) for 1 h at 37uC. The cells were fixed
with 4% PFA in PBS (pH 7.4) for 20 min at room temperature,
followed by permeabilization with 0.2% Triton X-100. Non-
specific binding was blocked with 5% normal goat serum
(Invitrogen) for 1 h. Then cells were incubated with rabbit
polyclonal anti-human p65 antibody (1:100, Abcam) overnight at
4uC, followed by incubation with Alexa Fluor 488-conjugated goat
anti-rabbit IgG (1:200, Invitrogen) for 1 h at room temperature.
Nuclei were stained with DAPI (Vector Laboratories). Images
were taken using a fluorescence microscope (Nikon, Japan) and
quantification was performed using Image-Pro Plus software. The
number of total cells and nuclei-positively stained cells were
counted from eight randomly chosen high-power (6200) fields in
each well. Each assay was performed in quadruplicate.
Statistical analysis
Data are presented as means 6 SEM and were determined
using either two-tailed t-test analysis or one-way ANOVA followed
by Fisher’s exact test analysis. P values less than 0.05 were
considered statistically significant.
Results
CD40 deficiency inhibits up-regulation of TRAFs in
response to vascular injury
Overexpression of CD40 and its adaptor proteins TRAFs have
been observed in established atherosclerotic plaques and in
developed neointimal lesions (28d) after carotid artery ligation
[14,23]. Using immunohistochemistry, we examined the expres-
sion pattern and changes for CD40 and TRAFs in the arterial wall
at different time points after carotid artery ligation. Our data
showed a significant increase in CD40 expression both in the early
phase (3d, 7d) and the late phase (21d) in WT mice (Figure 1A),
and the increase in CD40 was accompanied by a parallel increase
in TRAFs, including TRAF6 (Figure 1C) and TRAF1/2/3/5
(Figure S2). Increased expression of CD40 in the injured arterial
wall was confirmed at the mRNA level as determined by real-time
RT-PCR (Figure 1B). In contrast, the injury-induced expression of
all TRAFs was almost completely abolished in the CD40-deficient
mice at all time points after the injury. Our data showed for the
first time that CD40 is essential for the upregulation of TRAF
proteins in response to vascular injury.
CD40 deficiency inhibits proinflammatory gene
expression and leukocytes recruitment
Recruitment of circulating leukocytes to the injured arterial wall
has been shown to be an initial step and play a critical role in
vascular inflammatory response and neointima formation [24].
Previous data have shown that CD40 deficiency reduced the
infiltration of inflammatory cells, including CD45+ total leuko-
cytes and CD3+ T cells in the developed (28d) neointimal lesions
[14], but the underlying mechanism remains largely unknown. In
the present study, we examined by immunohistochemistry the
effects of CD40 deficiency on leukocuyte recruitment at different
time points and explored the molecular mechanisms involved.
In wild-type mice, neutrophil infiltration was dramatically
increased at 3d after carotid injury, prominently seen in the
adventia and on the lumen surface, but modest in the media
(Figure 2). However, neutrophil infiltration became very evident in
the media at 7 days after the injury (Figure 2A). Mac-2+monocyte/
macrophages were limited at 3 days (data not shown), but became
evidentinthemedia(7d)andtheninthedevelopingneointima(21d)
(Figure 2B). In CD40
2/2 mice, absence of CD40 profoundly
reduced the number of infiltrated neutrophils and monocyte/
macrophages at all the indicated time points after carotid artery
ligation (Figure 2). In addition, we observed that neutrophil
recruitment in a model of thioglycollate-induced peritonitis is
impaired in CD40-deficient mice (Figure 2C). The reduction in
leukocytes recruitment into the injured vessel wall and the
peritoneal cavity of CD40
2/2 mice was not due to lower levels of
blood leukocytes, because complete blood cell count results showed
no detectable differences in levels of total leukocytes or specific
leukocyte subtypes between CD40
2/2 and WT mice (Table S1).
To elucidate the molecular mechanisms underlying the CD40-
mediated effects on leukocyte recruitment, we examined the
expression of proinflammatory genes in the ligated carotid arteries.
Immunohistochemical staining demonstrated that the expression
of adhesion molecules (ICAM-1, VCAM-1) and chemokine MCP-
1 was markedly increased at 3 and 7 days after injury in wildtype
mice (Figure 3, A to C), but the increase of all these
proinflammatory mediators was markedly blocked in CD40
2/2
mice at all time points (Figure 3, A to C). Consistent with
immunostaining results, real-time RT-PCR analysis confirmed a
significant reduction in mRNA expression of ICAM-1, VCAM-1,
and MCP-1 in the CD40-null carotid arteries compared with the
WT arteries at 3 and 7 days after injury (Figure 3D). Moreover,
real-time RT-PCR analysis demonstrated that the mRNA levels of
proinflammatory cytokines including TNF-a, IL-6, and IL-1b,
were markedly increased in the WT carotid arteries at 3 and 7
days after injury, but the levels were much lower in CD40
2/2
mice (Figure 3D). These cytokines are known to potently stimulate
expression of various adhesion molecules and chemokines in
vascular cells and leukocytes in vivo and in vitro [25]. Plasma
levels of MCP-1 and soluble VCAM-1 in CD402/2 mice were
lower than WT controls, but not reaching statistical significance
(Figure S5).
CD40 deficiency inhibits NF-kB activation in the arterial
wall in response to vascular injury and in leukocytes in
vitro
In vitro data have shown that CD40-TRAF interaction triggers
activation of NF-kB, a major transcription factor that regulates
expression of many different proinflammatory genes [26,27],
including those genes we examined above. However, there is no in
vivo data indicating whether/how CD40 mediates vascular
inflammation through a NF-kB-dependent mechanism after
vascular injury. We examined NF-kB activation by immunostain-
ing of total NF-kB p65 and its activated form of phospho-p65 in
the injured carotid artery. In wildtype mice, immunostaining for
both p65 and phosphor-p65 was markedly increased at 3 and
7days after carotid ligation (Figure 4, A and B), findings in general
agreement with previous studies [28–30]. In CD40
2/2 mice, the
injury-induced upregulation of p65 and phosphor-p65 was largely
inhibited at both time points (Figure 4, A and B).
Because previous data show that leukocyte CD40 plays a
predominant role in neointima formation after carotid artery
ligation [14], we further examined whether CD40 is required for
CD40L-induced activation of NF-kB pathway in leukocytes.
Translocation of cytoplasmic NF-kB p65 to the nucleus is a key
step in activation of the NF-kB pathway [26,27]. By immunoflu-
orescence staining, we demonstrated that CD40L stimulation
induced NF-kB p65 translocation from the cytoplasm to the
nucleus in wild-type neutrophils, but this effect was largely
inhibited in CD40-deficient neutrophils (Figure 5).
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evidence that CD40 plays a critical role in mediating proin-
flammatory gene expression and leukocyte infiltration possibly via
activation of NF-kB-dependent mechanism.
CD40 deficiency reduces neointima formation in two
different injury models
Because neointima formation may vary significantly depending
on the nature of vascular injury, we examined and compared the
effects of CD40 deficiency on neointima formation and arterial
remodeling using two different injury models. In the carotid artery
ligation model, our results reproduced previous observations [14].
Compared with wildtype mice, neointimal size and intima/media
ratios were significantly reduced in CD40
2/2 mice, with
significant reduction in lumen stenosis (Figure S3). Consistent
with the published data [14], we showed that CD40
2/2 mice
exhibited impaired arterial remodeling after carotid ligation, i.e.
total vessel size of CD40
2/2 mice was significantly smaller than
that of wild-type mice (Figure S4A). It could not be explained by
differences in carotid geometry, since there were no differences in
uninjured carotid arteries between both genotypes, with respect to
the lumen area, media area, and total vessel area (Figure S4B).
Wire denudation injury can induce significant neointima
formation in the femoral artery, although the extent of neointimal
lesion often varies among different laboratories. The extent of
neointima formation of WT mice on C57BL/6 background shown
in our study was similar to those reported by other laboratories
[31,32]. In this model, we demonstrated that neointimal size,
intima/media ratios, and lumen stenosis were significantly reduced
in CD402/2 mice (Figure 6), findings in agreement with those
obtained in the carotid ligation model. It warrants to note that,
unlike carotid artery ligation model, vascular remodeling was not
Figure 1. Expression of CD40 and TRAFs in the carotid artery wall after ligation injury. (A) Representative images of immunostaining for
CD40 in carotid arteries from WT and CD40
2/2 mice (n=5 per group). Scale bars: 20 mm or 100 mm. (B) Quantitative RT-PCR analysis of CD40
expression in WT carotid arteries (n=5 per group). mRNA levels are normalized to GAPDH. Data are expressed as mean 6 SEM. * P,0.05 and
** P,0.01 versus uninjured (uninj.)control. (C) Representative images of immunostaining for TRAF6 in carotid arteries from WT and CD40
2/2 mice
(n=5 per group). Scale bars: 20 mm. Arrows indicate the internal elastic lamina.
doi:10.1371/journal.pone.0023239.g001
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2/2 mice compared with wild-type mice after
femoral artery denudation, i.e. total vessel size was similar in both
types of mice (Figure S4A). In addition, no difference in vessel
geometry were found in uninjured femoral arteries between both
genotypes (Figure S4C).
Discussion
This study elucidates a cellular/molecular mechanism of the
CD40 signaling involved in the response to vascular injury:
increased expression of CD40 and its adaptor TRAF proteins and
activation of the NF-kB-dependent proinflammatory pathway. We
observed that CD40 deficiency profoundly inhibits expression of
TRAF proteins and activation of NF-kB that involves gene
expression of proinflammatory cytokines and adhesion molecules
in the injured arterial wall and thus, the CD40 signaling pathway
plays a crucial role in mediating inflammatory response and
leukocyte recruitment in vivo. The results also firmly establish the
functional role of CD40 in neointima formation in two distinct
vascular injury models.
Overexpression of CD40 and TRAFs (-1,-2,-3,-5,-6) has been
observed in murine and human atherosclerotic lesions [23,33].
Figure 2. CD40 deficiency inhibits leukocytes recruitment into the carotid artery wall after ligation injury, and thioglycollate-
induced peritoneal leukocyte recruitment. Representative images of immunostaining for neutrophils (anti-PMN mAb) (A) and for Mac-2-
positive monocyte/macrophages (B) in carotid arteries from WT and CD40
2/2 mice (n=5 per group). Positively stained cells were quantified as
described in Method. Arrows indicate the internal elastic lamina. Scale bars: 20 mm. Data are expressed as mean 6 SEM. ** P,0.01 versus
corresponding WT. (C) Neutrophil recruitment in a model of thioglycollate-induced peritonitis is impaired in CD40-deficient mice. Mice were treated
i.p. with 2 ml of 3% thioglycollate or the same volume of isotonic saline. 5 hours later, total number of neutrophils (610
6) in the peritoneal cavity was
counted. n=5 mice/group.
doi:10.1371/journal.pone.0023239.g002
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atherogenesis. Although overall deletion of CD40 did not limit
atherogenesis in LDLr
2/2CD40
2/2 mice [34], overall deletion of
CD40 significantly limited atherogenesis in apoE
2/2CD40
2/2
mice [35]. The exact reasons for this discrepancy are unclear at
present. Increased expression of CD40 and several TRAFs
including TRAF6 has also been observed in developed neointimal
lesions after vascular injury [14]. In vitro data show that CD40L
and other proinflammatory cytokines modulate TRAFs differen-
tially in ECs, SMCs, and macrophages [23]. For example, ligation
of CD40 by CD40L enhanced the expression of TRAF-1, -2, -3,
and 6, but not TRAF-5 in ECs. Stimulation with IL-1b or TNF-a
induced expression of TRAF-1, -3, and -6 in ECs and SMCs,
whereas neither stimulus affected the expression of TRAF-2 or -5
[23]. However, it remains unknown about how CD40 and TRAFs
are upregulated in the damaged arterial wall in vivo. In the present
study, we used CD40-deficient mice to determine whether CD40
is required for the injury-induced expression of TRAFs at different
time points after carotid artery ligation. We observed that absence
of CD40 almost completely abolished the induction of TRAFs,
indicating an essential role of CD40 in the upregulation of TRAF
proteins after vascular injury.
It has been reported that different TRAFs differentially
contribute to the development of atherosclerosis. Lutgens et al
[32] reported that deficient CD40-TRAF6 signaling in leukocytes
prevents atherosclerosis in apolipoprotein E knockout mice. In
contrast, Stachon et al [36] reported that TRAF6 deficiency does
not influence atherogenesis in LDLR2/2 mice. Missiou et al
[37,38] reported that TRAF5 deficiency accelerates, by contrast,
TRAF1 deficiency attenuates atherogenesis in LDLR2/2 mice.
More recently, Donners et al [14] demonstrated that bone
marrow-derived leukocyte CD40 appeared to play a dominant
role in neointima formation after carotid artery ligation, but the
role of CD40 expressed by non-hematopoietic cells (vascular wall
cells) was not examined in the study.
Emerging evidence indicates that many of the biological effects
of TRAF signaling appear to be mediated through the activation
of transcription factor NF-kB [7,39]. NF-kB plays a key role in
regulating the expression of many cytokines and adhesion
molecules involved in atherosclerosis and neointima formation
after vascular injury. The activation of NF-kB in the vessel wall
after arterial injury in rats and mice has been established by
several reports and has been correlated to the induced expression
of NF-kB-dependent proinflammatory genes such as VCAM-1
Figure 4. CD40 deficiency inhibits NF-kB activation in the carotid artery wall after ligation injury. Representative cross-sections from
carotid artery immunostained for total NF-kB p65 (A) and activated phospho-p65 (Ser536) (B), as well as their quantitative analysis, in WT and
CD40
2/2 mice (n=5 per group). Arrows indicate the internal elastic lamina. Scale bars: 20 mm. Data are expressed as mean 6 SEM. ** P,0.01 versus
corresponding WT.
doi:10.1371/journal.pone.0023239.g004
Figure 3. CD40 deficiency inhibits expression of proinflammatory mediators in the carotid artery wall after ligation injury.
Representative cross-sections from carotid arteries immunostained for ICAM-1 (A), VCAM-1 (B), and MCP-1 (C), as well as their quantitative analysis, in
WT and CD40
2/2 mice (n=5 per group). Arrows indicate the internal elastic lamina. Scale bars: 20 mm. Data are expressed as mean 6 SEM. ** P,0.01
versus corresponding WT. (D) Quantitative RT-PCR analysis of mRNA expression of ICAM-1, VCAM-1, MCP-1, TNF-a, IL-6, and IL-1b, in WT and CD40
2/2
carotid arteries from WT and CD40
2/2 mice (n=5 per group). mRNA levels are normalized to GAPDH. Data are expressed as mean 6 SEM. * P,0.05
and ** P,0.01 versus corresponding WT.
doi:10.1371/journal.pone.0023239.g003
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by overexpression of IkBa [41] blockade of IKKb [42] or with NF-
kB decoy [43] inhibited vascular inflammatory responses and
neointimal formation. To best of our knowledge, however, no in
vivo studies have documented the role of CD40 in regulation of NF-
kB activation and NF-kB-dependent gene expression intheinjured/
diseased arteries. The present study observed robust activation of
NF-kB in the carotid artery wall in the early phase (3, 7d) after
injury, accompanied by increased expression of cytokines (TNF-a,
IL-1b,IL-6), chemokineMCP-1,andadhesion molecules (ICAM-1,
VCAM-1), as well as abundant recruitment of neutrophils sand
monocyte/macrophages. In vitro, the present data confirmed that
CD40 deficiency inhibited CD40L-induced NF-kB nuclear trans-
location in neutrophils. Notably, the activation of NF-kB and the
increased expression of all these genes and leukocyte recruitment all
are markedly inhibited in CD402/2 mice.
Proinflammatory cytokines, TNF-a, IL-1b, and IL-6, play a key
role in mediating adhesion molecule expression and immune cell
activation [24,44]. ICAM-1 and VCAM-1 are the adhesion
molecules of immunoglobulin family responsible for the firm arrest
and transmigration of leukocytes into inflammatory sites [45].
MCP-1 is a key chemokine that stimulate monocyte adhesion and
accumulation in diseased vessel [44]. All these proinflammatory
mediators have been implicated in the process of neointima
formation after vascular injury [24]. Inhibition of cytokines or
adhesion molecules decreased neointima formation after vascular
injury [46,47]. Therefore, we conclude that CD40 deficiency
reduces leukocyte recruitment and neointima formation through
downregulating activation of NF-kB and NF-kB-dependent
upregulation of multiple pro-inflammatory genes in the injured
arterial wall.
The carotid artery ligation model and the femoral artery wire
denudation model are both widely used to investigate the
pathophysiology of neointima formation after vascualr injury. In
the ligation model, the arterial endothelium and the internal elastic
lamina (IEL) and the external elastic lamina (EEL) are generally
intact (Figs. S1B, S3A). In the wire injury model, the arterial
endothelium are removed (Fig. S1A), the medial layer including
IEL is partially damaged, but EEL is generally intact (Figure 6A).
The compositions of the neointimal lesions in both models include
SMC-like cells, infiltrating leukocytes and extracellualr matrix.
But, the exact cellular composition of the lesions may be different
significantly among models [17,18,48]. It is well known that
neointima formation might be diverse depending on the type of
vascular injury [16,17]. For example, genetic deletion of the
integrin b3 significantly reduced neointima formation after carotid
artery ligation, but increased neointima formation after femoral
artery wire-denudation injury [16]. Similarly, genetic deletion of
CD40L significantly increased neointima formation after carotid
collar injury [15], but decreased neointima formation after carotid
artery ligation [14]. Therefore, it is particularly important to
establish the role of CD40 in neointima formation using different
vascular injury models. Increasing evidence has shown that the
CD40L-mediated effects are not necessarily identical to the CD40-
mediated effects [8]. This is because that CD40 is not the only
receptor for CD40L, e.g. CD40L can bind to other receptors such
as GPIIb/IIIa in platelets and Mac-1 in leukocytes [8]. Likewise,
CD40L is not the only protein that interacts with CD40, e.g. other
proteins such as HSP70 can interact with CD40 [49]. The present
study firmly established the role of CD40 deficiency in neointima
formation using carotid artery ligation model and guidewire-
induced femoral artery denudation model performed in the same
mouse. Neointimal lesions and lumen stenosis were consistently
reduced in CD40
2/2 mice in both models. Only difference is that
arterial remodeling was impaired in the ligated carotid artery, but
not impaired in the wire-denudated femoral artery of CD402/2
mice. The mechanism is not clear at present.
Limitations of the study and future research: Several important
questions remain to be addressed in the future research. For
example, what are the cell types in the 2 different injury models
that express CD40 and the respective TRAF molecules? Which
NF-kB pathway is activated/prevented, canonical or non-canon-
ical, and which TRAFs are involved in the canonical/non-
canonical pathway in neointima formation?
In summary, the novelty of the present study is that we
identified for the first time that CD40 is essential in the
upregulation of TRAF proteins and NF-kB-dependent proinflam-
matory genes in vivo. Also importantly, our study firmly
established the role for CD40 in neointima formation in 2 distinct
vascular injury models. These findings may provide valuable
Figure 5. CD40 is required for CD40L-induced activation of
NF-kB pathway in neutrophils. (A) NF-kB nuclear translocation was
assessed by immunofluorescence staining for NF-kB p65 (green) in
wildtype and CD40-deficient neutrophils exposed to CD40L (1.0 mg/ml)
for 1 h. Cell nuclei were detected by DAPI (blue). Scale bars: 50 mm. (B)
NF-kB nuclear translocation was assessed and quantified as the
percentage of the p65 nuclei-positively stained cells to the total cells.
Similar results are obtained from three independent experiments. Data
are expressed as mean 6 SEM. ** P,0.01 versus WT.
doi:10.1371/journal.pone.0023239.g005
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Supporting Information
Figure S1 Removal of the endothelium was confirmed
by in vivo Evan’s blue staining 4 h after vascular injury.
Briefly, 1% Evans blue (in 200 ı `L saline) was injected intracardially
10 minutes before sacrifice, followed by perfusion fixation with
10% formalin for 5 minutes. Arteries were opened longitudinally
and placed en face between microscopic slides. A, Wire-injured left
and uninjured right femoral artery (FA). B, (left) Wire-injured
common carotid artery (CCA), and (right) suture ligation-injured
CCA.
(PDF)
Figure S2 Effects of CD40 deficiency on TRAFs expres-
sion in the carotid artery wall after ligation injury.
Representative cross-sections from carotid arteries immunostained
for TRAF1 (A), TRAF2 (B), TRAF3 (C), TRAF5 (D) in WT and
CD40
2/2 mice (n=5 per group). Arrows indicate the internal
elastic lamina. Scale bars: 20 mm.
(PDF)
Figure S3 Decreased neointima formation and lumen
stenosis after carotid artery ligation in CD40
2/2 mice.
(A) Representative Elastic-stained sections (level 3) of carotid
arteries 21d after injury in WT and CD40
2/2 mice (left panel).
Schematic diagram of carotid artery ligation and tissue microtomy
(right panel). Arrows indicate the internal elastic lamina. Scale
bars: 50 mm. (B) Intima was measured at the 7 cross-section levels
(120-mm intervals), and their mean intimal area was calculated.
Intima/media ratio (C) and lumen stenosis ratio (D) at each level
as well as their mean ratios were determined. n=10 mice per
group. Data are expressed as mean 6 SEM. * P,0.05 and **
P,0.01 versus corresponding WT.
(PDF)
Figure S4 Effects of CD40 deficiency on arterial remod-
eling after injury. (A) Total vessel area was measured in carotid
arteries and femoral arteries 21d after injury in WT and CD40
2/2
mice. n=10 mice per group. Data are expressed as mean 6 SEM.
** P,0.01 versus WT. Lumen area, media area, and total vessel
area were measured in uninjured carotid arteries (B) and
uninjured femoral arteries (C) from WT (n=7 vessel) and
CD40
2/2 mice (n=6 vessel). Data are expressed as mean 6
SEM. No differences in vessel geometry were found between WT
and CD40
2/2 mice in uninjured arteries.
(PDF)
Figure S5 Measurement of plasma levels of MCP-1 and
soluble VCAM-1 using Quantikine Mouse ELISA Kits
(R&D Systems) in CD402/2 mice and WT controls. NS:
P.0.05. n=5/group.
(PDF)
Table S1 Complete blood cell counts.
(PDF)
Table S2 Primer sequences for real-time RT-PCR.
(PDF)
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